Log in

CVE:VIRViridium Pacific Group Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume26,500 shs
Average Volume92,632 shs
Market CapitalizationC$37.54 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-837-8688

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.09 million
Book ValueC$0.29 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$37.54 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VIR News and Ratings via Email

Sign-up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter.

Viridium Pacific Group (CVE:VIR) Frequently Asked Questions

Has Viridium Pacific Group been receiving favorable news coverage?

Media stories about VIR stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Viridium Pacific Group earned a news sentiment score of -3.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Viridium Pacific Group.

Who are some of Viridium Pacific Group's key competitors?

What other stocks do shareholders of Viridium Pacific Group own?

Who are Viridium Pacific Group's key executives?

Viridium Pacific Group's management team includes the following people:
  • Mr. Jay Garnett, Pres, CEO & Director (Age 50)
  • Mr. Jarrett Malnarick, Sr. VP, COO & Director (Age 46)
  • Ms. Sze Wan Wong C.A., CPA, CA, CPA, Corp. Sec. & Strategic Advisor (Age 45)
  • Ms. Kamini Hitkari, Chief Financial Officer
  • Mr. Bob Howard, Exec. Officer

What is Viridium Pacific Group's stock symbol?

Viridium Pacific Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIR."

How do I buy shares of Viridium Pacific Group?

Shares of VIR and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Viridium Pacific Group?

Viridium Pacific Group has a market capitalization of C$0.00 and generates C$1.09 million in revenue each year.

What is Viridium Pacific Group's official website?

The official website for Viridium Pacific Group is www.viridiumpacific.com.

How can I contact Viridium Pacific Group?

The company can be reached via phone at 604-837-8688.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.